Effect of Stimforte on infection induced by hepatitis C virus, genotype 1b


Cite item

Full Text

Abstract

When given at two concentrations of 12.5 and 25 mg/kg to mice weighing 18-20 g in chronic infection, the novel immunomodulator Stimforte was tested for effects on replication of hepatitis C virus (HCV), 1b strain. The efficacy of the agent was evaluated from the decrease in virus titers in the liver, serum, brain, and spleen and from the reduction of antigen titers in the same organs. When administered at a concentration of 12.5 mg/kg, the agent was ineffective and did not decrease significantly the examined indices in any of the organs. When used at a concentration of 25 mg/kg, Stimforte significantly lowered the number of virus antigen in the study organs, rather than in the serum, the liver showing a 15-fold antigen reduction as compared with the controls. HCV replication decreased by 2.4 log10 in the serum and 1.7-1.9 log10 in the organs of the animals given the agent. A Stimforte-induced decrease in HCV replication correlated well with the increased concentration of proinflammatory cytokines (tumor necrosis factor-α, interferon-γ, interleukin (IL)-6, IL-1β, which might be one of the mechanisms responsible for the antiviral activity of the agent in hepatitis C.

References

  1. Дерябин П. Г., Исаева Е. И., Вязов С. О., Львов Д. К. Летальная инфекция новорожденных мышей, вызванная вирусом гепатита С // Вопр. вирусол. - 1997. - № 6. - С. 251-253.
  2. Дерябин П. Г., Вязов С. О., Исаева Е. И. и др. Персистенция вируса гепатита С в культурах клеток головного мозга мышей-сосунков // Вопр. вирусол. - 1997. - № 6. - С. 254-258.
  3. Дерябин П. Г., Львов Д. К. Высокопродуктивный вариант вируса гепатита С. Выделение, характеристика, идентификация // Докл. РАН. - 1998. - Т. 358, № 5. - С. 688-691.
  4. Мальдов Д. Г., Хоперская О. А. Получение иммуностимулирующего средства. - Пат. № 008645, 2006, РФ.
  5. Хаитов Р. М., Пинегин Б. В. Основные принципы иммуномодулирующей терапии // Иммунология. - 2003.
  6. Auffermann-Gretzinger S., Keeffe E. B., Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection // Blood. - 2001. - Vol. 97. - P. 3171-3176.
  7. Bronowicki J. P., Loriot M. A., Thiers V. et al. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice // Hepatology. - 1998. - Vol. 28, N 1. - P. 211-218.
  8. Calabrese L. H., Zein N., Vassilopoloulos D. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection //Ann. Rheum. Dis. - 2004. - Vol. 63. - Suppl. 2. - P. ii18-ii24.
  9. Ciccaglione A. R., Stellacci E., Marcantonio C. et al. Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes // Hepatology. - 2007. - Vol. 28. - P. 211-218.
  10. Clarke D. H., Casals J. Techniques for hemagglutination and hemagglutination-inhibition wit arthropod-borne viruses // Am. J. Trop. Med. Hyg. - 1958. - Vol. 7, N 5. - P. 561-573.
  11. de Lucas S., Bartolome J., Carreno V. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes // J. Infect. Dis. - 2004. - Vol.191. - P. 93-99.
  12. Dolganiuc A., Chang S., Kodys K. et al. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection // J. Immunol. - 2006. - Vol. 177, N 10. - P. 6758-6768.
  13. Guofeng Cheng, Jin Zhong, Francis V. Chisari. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms // Proc. Natl. Acad. Sci. USA. - 2006. - Vol. 103, N 22. - P. 8499-8504.
  14. Lerat H., Rumin S., Habersetzer F. et al. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype // Blood. - 1998. - Vol. 91. - P. 3841-3849.
  15. Radkowski M., Bednarska A., Horban A., Stanczak J. et al. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-a and interleukin 8 // J. Gen. Virol. - 2004. - Vol. 85. - P. 47-59.
  16. Rosen H. R., McHutchison J. G., Conrad A. J. et al. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C // Am. J. Gastroenterol. - 2002. - Vol. 97, N 3. - P. 714-720.
  17. Togashi H., Ohno S., Matsuo T. et al. Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress // Res. Commun. Mol. Pathol. Pharmacol. - 2000. - Vol. 107, N 5-6. - P. 407-417.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Deryabin P.G., Isaeva E.I., Mal'dov D.G., Il'ichev A.V., Pichugina L.V., L'vov D.K., Deryabin P.G., Isaeva E.I., Maldov D.G., Ilyichev A.V., Pichugina L.V., Lvov D.K.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies